April 29 | 2022 Rättelse: Korrektion till “Kallelse till årsstämma i 2cureX AB” utfärdad den 21 april 2022 Read more
April 22 | 2022 Korrektion till “Kallelse till årsstämma i 2cureX AB” utfärdad den 21 april 2022 Read more
April 22 | 2022 Correction of “Notice of annual general meeting of 2cureX AB (publ)” issued on 21st April 2022 Read more
April 21 | 2022 Manuel Fernández joins 2cureX as Director of Quality Assurance and Regulatory Affairs. Read more
April 14 | 2022 Chairman of the 2cureX Board exercises all warrants within the framework of the 2018 incentive program Read more
March 14 | 2022 2cureX launches IndiTreat® mCRC Explore and completes portfolio rollout plan for 2022 Read more
February 24 | 2022 2cureX publishes interim report for the fourth quarter and all 12 months of 2021 Read more
February 24 | 2022 2cureX offentliggör delårsrapport för det fjärda kvartalen och alla tolv månader 2021 Read more
February 23 | 2022 2cureX holds a virtual live-session on the 25th of February 2022 to present and discuss the Interim report for the fourth quarter of 2021. Read more
January 11 | 2022 IndiTreat® to be distributed in Czech Republic and Slovakia through Promedica Read more